Yulei Wang

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Venues

Nature communications

Nature medicine

Nature

Journal of hepatocellular carcinoma

Genentech

The University of Chicago (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Genentech Dec 07 2010

United States

Principal Scientist :: Oncology Biomarker Development

Applied Biosystems

United States

Sr. Staff Scientist :: Research and Development

Education History

The University of Chicago

United States

PHD :: Chemistry

Peking University

China

BSC :: Chemistry

Publications

Guadalupe Ortiz-Muñoz, Markus Brown, Catherine B Carbone, Ximo Pechuan-Jorge, Vincent Rouilly, Henrik Lindberg, Alex T Ritter, Gautham Raghupathi, Qianbo Sun, Tess Nicotra, Shreya R Mantri, Angela Yang, Jonas Doerr, Deepti Nagarkar, Spyros Darmanis, Benjamin Haley, Sanjeev Mariathasan, Yulei Wang, Carlos Gomez-Roca, Carlos Eduardo de Andrea, David Spigel, Thomas D Wu, Lelia Delamarre, Johannes Schöneberg, Zora Modrusan, Richard Price, Shannon J Turley, Ira Mellman, Christine Carine Moussion
In situ tumour arrays reveal early environmental control of cancer immunity. Nature (2023)
Alessandra Castiglioni, Yagai Yang, Katherine Williams, Alvin Gogineni, Ryan S Lane, Amber W Wang, Justin A Shyer, Zhe Zhang, Stephanie Mittman, Alan Gutierrez, Jillian L Astarita, Minh Thai, Jeffrey Hung, Yeqing Angela Yang, Tony Pourmohamad, Patricia Himmels, Marco De Simone, Justin Elstrott, Aude-Hélène Capietto, Rafael Cubas, Zora Modrusan, Wendy Sandoval, James Ziai, Stephen E Gould, Wenxian Fu, Yulei Wang, James T Koerber, Shomyseh Sanjabi, Ira Mellman, Shannon J Turley, Sören Müller
Combined PD-L1/TGFβ blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumors. Nature communications 14 (1) (2023)
Ahmed O Kaseb, Yinghui Guan, Betul Gok Yavuz, Alexander R Abbas, Shan Lu, Elshad Hasanov, Han Chong Toh, Wendy Verret, Yulei Wang
Serum IGF-1 Scores and Clinical Outcomes in the Phase III IMbrave150 Study of Atezolizumab Plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 9 (2022)
Andrew X Zhu, Alexander R Abbas, Marina Ruiz de Galarreta, Yinghui Guan, Shan Lu, Hartmut Koeppen, Wenjun Zhang, Chih-Hung Hsu, Aiwu Ruth He, Baek-Yeol Ryoo, Thomas Yau, Ahmed O Kaseb, Adam M Burgoyne, Farshid Dayyani, Jessica Spahn, Wendy Verret, Richard S Finn, Han Chong Toh, Amaia Lujambio, Yulei Wang
Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma. Nature medicine 28 (8) (2022)
Mélanie Desbois, Yulei Wang
Cancer-associated fibroblasts: Key players in shaping the tumor immune microenvironment. Immunological reviews 302 (1) (2021)
Mélanie Desbois, Akshata R Udyavar, Lisa Ryner, Cleopatra Kozlowski, Yinghui Guan, Milena Dürrbaum, Shan Lu, Jean-Philippe Fortin, Hartmut Koeppen, James Ziai, Ching-Wei Chang, Shilpa Keerthivasan, Marie Plante, Richard Bourgon, Carlos Bais, Priti Hegde, Anneleen Daemen, Shannon J Turley, Yulei Wang
Integrated digital pathology and transcriptome analysis identifies molecular mediators of T-cell exclusion in ovarian cancer. Nature communications 11 (1) (2020)

Yulei Wang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yulei Wang